Skip to content
Advertisement

A nurse administers a COVID-19 vaccine to Josepha Delmotte, 102 years old, center, at La Bonne Maison de Bouzanton care home in Mons, Belgium, Monday, Dec. 28, 2020. The vaccine, developed by BioNTech and Pfizer, was transported from a hospital in Leuven to the residential care home on Monday, as Belgium begins its vaccination program starting with the most vulnerable. Also being vaccinated, nurse Marie-Catherine Van Broeck, second right, and Toni Agostinelli, left, who both work at the home. (AP Photo/Francisco Seco, Pool)

A nurse administers a COVID-19 vaccine to Josepha Delmotte, 102 years old, center, at La Bonne Maison de Bouzanton care home in Mons, Belgium, Monday, Dec. 28, 2020. The vaccine, developed by BioNTech and Pfizer, was transported from a hospital in Leuven to the residential care home on Monday, as Belgium begins its vaccination program starting with the most vulnerable. Also being vaccinated, nurse Marie-Catherine Van Broeck, second right, and Toni Agostinelli, left, who both work at the home. (AP Photo/Francisco Seco, Pool)

Featured Photo Galleries